CCL2 and stage 5 chronic kidney disease: Gender, age, BMI, course of disease, FPG, glycosylated hemoglobin, BUN, Scr, IL-6, MCP-1, and NF-κB were used as single factors, and the occurrence of end-stage renal disease was the end point.